10-K: U.S. Physical Therapy, Inc. Reports 2023 Financial Results, Outlines Strategic Growth Initiatives

U.S. Physical Therapy, Inc. reports a 9.3% increase in total net revenue for 2023, driven by clinic additions and increased patient volume, while also facing challenges from Medicare reimbursement rate decreases.

Summary

• U.S. Physical Therapy, Inc. (USPH) operates through two segments: physical therapy operations and industrial injury prevention services (IIP).
• The company's total net revenue for 2023 increased by 9.3% to $604.8 million, compared to $553.1 million in 2022.
• Operating costs also increased by 9.6% to $483.3 million in 2023, up from $441.1 million in 2022.
• Gross profit for 2023 was $121.5 million, representing 20.1% of net revenue, compared to $112.0 million, or 20.3% of net revenue, in 2022.
• Net income attributable to USPH shareholders was $28.2 million in 2023, down from $32.2 million in 2022, which included a non-cash impairment charge of $17.5 million.
• Earnings per share for 2023 were $1.28, compared to $2.25 in 2022.
• The company operated 671 clinics in 42 states as of December 31, 2023, an increase from 640 clinics at the end of 2022.
• In 2023, USPH completed several acquisitions, including clinic practices and IIP businesses.
• A secondary offering of common stock in May 2023 generated net proceeds of $163.6 million, which were used to repay debt and fund acquisitions.
• Medicare reimbursement rates are expected to decrease by approximately 3.5% in 2024, impacting future revenue.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While there is positive growth in revenue and clinic expansion, there are also significant challenges such as decreased net income, impairment charges, and expected Medicare reimbursement rate reductions. The company is also exposed to various risks, which tempers the overall positive outlook.

Positives

• The company achieved a 9.3% increase in total net revenue, demonstrating strong growth.
• USPH expanded its clinic network to 671 locations, increasing its market presence.
• The secondary offering provided significant capital for debt reduction and future acquisitions.
• The company experienced a record-high average daily visits per clinic, indicating strong demand for services.
• Adjusted EBITDA and Operating Results both increased year-over-year, reflecting improved operational performance.

Negatives

• Net income attributable to USPH shareholders decreased to $28.2 million in 2023 from $32.2 million in 2022.
• The company recorded a non-cash impairment charge of $17.5 million in 2023.
• Net rate per patient visit decreased to $102.80 in 2023 from $103.63 in 2022.
• Medicare reimbursement rates are expected to decrease by approximately 3.5% in 2024, which will negatively impact revenue.

Risks

• Decreases in Medicare reimbursement rates may adversely affect financial results.
• Revenue from Medicare and Medicaid is subject to potential retroactive reduction.
• The company depends on reimbursement by third-party payors, which may reduce payments.
• The company is subject to risks associated with public health crises and epidemics/pandemics.
• Debt and financial obligations could adversely affect the company's financial condition.
• Contingent consideration in acquisition agreements may impact future financial results.
• The company may be required to comply with a put right in one of its acquisition agreements.
• The company faces competition from other healthcare providers.
• A security breach, such as a cyber-attack, may cause a violation of HIPAA or HITECH.
• The company depends on hiring, training, and retaining qualified employees.

Future Outlook

The company intends to continue acquiring outpatient physical therapy practices, developing satellite clinics, and acquiring companies in the IIP sector. The company expects to continue adding personnel in the future as it focuses on potential acquisition targets and organic growth opportunities. The company anticipates a 3.5% decrease in Medicare reimbursement rates in 2024.

Management Comments

• The company's strategy is to continue acquiring outpatient physical therapy practices, develop outpatient physical therapy clinics as satellites in existing partnerships, and continue acquiring companies that provide or serve the Companys industrial injury prevention services sector.
• The company believes that its cash and cash equivalents and availability under its Credit Facilities are sufficient to fund the working capital needs of its operating subsidiaries through at least February 29, 2025.

Industry Context

The healthcare industry, including physical therapy and industrial injury prevention services, is highly competitive and fragmented. USPH is one of the largest national outpatient physical therapy services providers. The company's partnership strategy provides a competitive advantage. The industry is subject to extensive federal, state, and local regulations, and is influenced by political, economic, and regulatory changes.

Comparison to Industry Standards

• While the document does not provide specific industry benchmarks, USPH's growth in clinic numbers and patient visits suggests a strong position in the fragmented physical therapy market.
• The company's focus on acquisitions and partnerships is a common strategy in the healthcare services industry, similar to companies like Select Medical and ATI Physical Therapy.
• The company's reliance on Medicare and Medicaid reimbursement is a common factor in the industry, making it vulnerable to changes in government policies, similar to other healthcare providers.
• The company's expansion into industrial injury prevention services is a diversification strategy, similar to some larger healthcare companies that offer a range of services.
• The company's financial performance, including revenue growth and profitability, is comparable to other publicly traded healthcare service providers, though specific comparisons would require more detailed industry data.

Corporate Governance

Legal Proceedings

• The company is a party to various legal actions, proceedings, and claims, and regulatory and other governmental audits and investigations in the ordinary course of business.
• In 2019, a qui tam lawsuit was filed against the company and one of its subsidiaries, which was settled in January 2022 with no admission of liability.

Related Party Transactions

• For the year ended December 31, 2021, the Company recorded approximately $20,000 related to the short swing profit settlement remitted by a shareholder of the Company under Section 16(b) of the Securities Exchange Act of 1934, as amended.

Stakeholder Impact

• Shareholders may be concerned about the decrease in net income and the expected reduction in Medicare reimbursement rates.
• Employees may be affected by changes in compensation and benefits.
• Customers may experience changes in service delivery due to clinic expansions and acquisitions.
• Suppliers may see increased business opportunities due to the company's growth.
• Creditors may be impacted by the company's debt obligations and financial performance.

Next Steps

• The company plans to continue acquiring outpatient physical therapy practices.
• The company intends to develop outpatient physical therapy clinics as satellites in existing partnerships.
• The company will continue acquiring companies that provide or serve the Companys industrial injury prevention services sector.
• The company will continue to monitor for any triggering events or other indicators of impairment.

Key Dates

Keywords

physical therapy, industrial injury prevention, healthcare, acquisitions, Medicare, reimbursement, revenue, EBITDA, financial results, clinic operations